The first question we faced as we gathered to discuss the possibility of launching Evidence (then just called the new journal on evidence-based medicine, still no caps) was why (and if) we did need another medical journal in an highly competitive environment already full of those. Douglas Altman stated that we needed “less research, better research and research done for the right reasons” in his famous 1994 article “The Scandal of Poor Medical Research.”(1) Adding to that, the predictive value of research in general is probably less than 50% (2), due to imprecision (low sample size), methodological bias (low quality of research design) and allegiance bias (conclusions being crafted in a manner that reconciles best with the investigator’s or researcher’s perspectives and preferences), not to mention P-hacking (3), withholding datasets and publication bias, that is, publishing only or mostly papers that disprove the null hypothesis.
So, yes, it is a very complex situation but, then again, so are most scientific investigations: full of variables, probabilities, informed guesses and very little certainty, which does not mean that we should give up on science and on the beauty of complexity and multifactoriality to help understand phenomena. Little certainty is perfectly fine and whatever evidence gathered – guaranteed it should be sound – is precious. And we should have a forum to discuss those issues openly and freely, apart from commercial pressures. That’s why we decided upon having Evidence.
The first purpose of the Journal of Evidence-based Healthcare is not just to provide more original research. We already have a lot of that too. Every nine years the scientific output doubles (4). Our aim is to promote the idea that, as consumers of science, we should be highly critical of the quality of information we are consuming. Scientific fake news is more dangerous than general fake news – both are based on assumptions that oversimplify phenomena, biases, or outright lies for personal gain. Scientific fake news seem more valid when it comes in the form of an original article, published in a scientific journal. One of the purposes of science in modern society is to inform policy and decision-making, which will then generally impact society as a whole (scientists included). And science has always been about doubting one’s own assumptions and trying to prove yourself wrong before you may reach some consensus. So, this is a call to not take evidence in a published paper at face value, but to keep the conversation going.
Evidence is all about that.
Therefore, our scope includes articles of critical appraisal of scientific literature, meta-science systematic reviews (describing scientific field’s behavior), good quality negative articles (which usually receives no attention or less than bad quality positive articles).
Our second purpose is to popularize the scientific culture among health professionals and society. Concept articles will be welcome to provide knowledge regarding not only scientific methodology but also how to translate scientific concepts into clinical decision. Insofar, as it has been stated before, by Ioannidis, and we concur, that research usefullness and projected social benefits should come before results (5). We could also rephrase that to: projected social impact should come before impact factor (which measures no impact altogether anyway). And to attain that, we must look into sound evidence.
Finally, original articles to validate tools for evidence-based decision making, such as diagnostic, prognostic and information regarding efficacy/effectiveness and share-decision making are also welcome to be submitted for publication.
More than a journal, we hope Evidence to be a community of people to promote the scientific culture among the public, differentiating science from pseudoscience. Our approach will be one of treating science informally (albeit rigorously), with the conviction that our conversation is about everyday life and should not be restricted to the academe because it has the power to inform how to better live, and that should be a shared commodity not a privilege. We are as of now unboxing science.
- Altman, DG. The scandal of poor medical research. BMJ. 1994 Jan 29;308(6924):283-4.
- Ioannidis JPA. Why Most Published Research Findings Are False. PLoS Med. 2005 Aug; 2(8): e124. doi: 10.1371/journal.pmed.0020124
- Colquhoun, D. The problem with p-values. Aeon Magazine. 2016 Oct 11. Available at https://aeon.co/essays/it-s-time-for-science-to-abandon-the-term-statistically-significant
- Bornmann L, Mutz R. Growth rates of modern science: A bibliometric analysis based on the number of publications and cited references. J Assoc Inf Sci Technol. 2014 May 08. arXiv:1402.4578 [cs.DL].
- Ioannidis JPA. Why Most Clinical Research Is Not Useful. PLoS Med 2016 Jun; 13(6): e1002049. doi: 10.1371/journal.pmed.1002049